Our company was born in the bio-pharmaceutical space when we acquired the US rights to a globally distributed treatment for hypertension. Building on this experience, we facilitated the FDA approval and manufacturing and distribution rights for a fixed-dose combination hypertension medication. We quickly came to realize that there were inefficiencies in the established big pharma distribution model. Lack of control over distribution and access to information have created a situation where manufacturers are unable to trace the path of their products from production to patient. With no connection between physician, patient and prescription, fulfillment data remained a mystery, making business analytics decisions unnecessarily difficult. With the goal of filling in these gaps, our patented DyrctAxess technology platform was developed and continues to evolve…
Q: What are medical foods?
A: Medical foods are foods that are specially formulated and intended for the dietary management of a disease that has distinctive nutritional needs that cannot be met by normal diet alone.
There is no denying that people are becoming increasingly concerned about what they use to fuel, maintain and heal their bodies. This trend is reflected in everything from the rising popularity of natural and healthy restaurant and supermarket options to books and documentaries exposing problems with the food and medical industries. Evidence of opportunity is everywhere: people are turning away from industrial chemicals in their food and medical treatments at rates never seen before. The global market is expected to increase at an annual growth rate of 6.9% through the year 2025 to a value of $24.4 billion.
Medical foods lie somewhere between prescription pharmaceuticals and nutritional supplements in how they are treated, opening up distribution channels unavailable for prescription pharmaceuticals. Leveraging the DyrctAxess model, BioMauris can help you penetrate new markets while gaining complete control over tracking your product movement and increasing patient retention.
With no requirements to be sold with a prescription and no NDC (National Drug Code) numbers, distributors do not need to be licensed pharmacies. BioMauris has extensive experience running direct distribution programs from our main facility. Utilizing our direct distribution services run on DyrctAxess technology has advantages when compared with strictly using retail pharmacies and drugstores:
Separating a newly-launched OTC product from the competition can be difficult when it is jockeying for shelf space with more established brands at superstores, franchised pharmacies and major e-commerce markets. At BioMauris, we have increased revenue and brand recognition for companies looking to raise awareness of their flagship products.
Take advantage of the powerful functions of DyrctAxess and let us help you implement a program that takes your products to the next level:
BioMauris has partnered with organizations which rely on relationships and networking to fuel their businesses but were unable to maximize their productivity due to deficiencies in their technological resources. We worked closely with these organizations to develop powerful, intuitive information management tools to increase their efficiency. BioMauris can manage contact information collected from website activity, send automated e-mail replies, create reports and dashboards and more.
It is just as important to strategize for the launch of a pipeline product as it is to work on increasing sales of an established one. BioMauris has helped several partners with pre-launch outreach and marketing campaigns. BioMauris will conduct in-depth, targeted outreach campaigns to the physicians most likely to prescribe or carry your product. All actions and responses are captured in DyrctAxess and follow up is performed accordingly by phone, mail or electronically. Using our direct distribution model, we easily support sample programs. Integrate your product website with DyrctAxess to capture and analyze website activity, which can be leveraged following launch of your product. Seamlessly implement a direct distribution program to increase product exposure.
BioMauris is experienced in managing research studies for companies looking to justify the public launch of their products. All participant communication, including initial qualification and follow up, is managed by our call center. Ship test product securely through our HIPAA-compliant distribution process. Surveys tracking participant response to treatment can be sent out electronically with results captured in DyrctAxess. All communication activities and product distribution information are tied to the participant. Leverage our robust reporting capabilities to analyze your outcomes and develop an appropriate BioMauris distribution program should your product go to market.
At BioMauris we believe in building partnerships, which is why our programs are based on a gain-share model. By tying our success to yours, our partners enjoy the peace of mind that our team is constantly going above and beyond to find ways to improve upon your program. Benefits of starting a partnership with BioMauris include: